G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 13.35 CNY -2.55%
Market Cap: 5.5B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

GemPharmatech Co Ltd
Investor Relations

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Jing Zhao Ph.D.
GM & Director
No Bio Available
Mr. Chongbo Xu CPA, M.B.A.
Chief Financial Officer
No Bio Available
Mr. Tao Wang
Deputy GM & Director
No Bio Available
Mr. Yiou Wang
Board Secretary
No Bio Available
Dr. Hong-Yu Wang Ph.D.
Chief Technology Officer
No Bio Available
Hongyan Sun
Deputy Director of Functional Pharmacodynamics Center
No Bio Available

Contacts

Address
JIANGSU
Nanjing
No. 12 Xuefu Road, Jiangbei New Area
Contacts